ELEVANCE HEALTH, INC. Lease, Cost
ELEVANCE HEALTH, INC. (ELV) reported Lease, Cost of $153.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-06
- ELEVANCE HEALTH, INC. lease, cost for the quarter ending 2023-12-31 was $43.00M, a 0.00% change year-over-year.
- ELEVANCE HEALTH, INC. lease, cost for the quarter ending 2023-09-30 was $68.00M, a 51.11% increase year-over-year.
- ELEVANCE HEALTH, INC. lease, cost for the quarter ending 2023-06-30 was $47.00M, a 9.30% increase year-over-year.
- ELEVANCE HEALTH, INC. lease, cost for the quarter ending 2023-03-31 was $37.00M, a 5.13% decline year-over-year.
- ELEVANCE HEALTH, INC. lease, cost for fiscal 2025 was $153.00M, a 18.62% decline from fiscal 2024.
- ELEVANCE HEALTH, INC. lease, cost for fiscal 2024 was $188.00M, a 2.59% decline from fiscal 2023.
- ELEVANCE HEALTH, INC. lease, cost for fiscal 2023 was $193.00M, a 10.29% increase from fiscal 2022.
- ELEVANCE HEALTH, INC. lease, cost for fiscal 2022 was $175.00M, a 42.05% decline from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $153.00M 10-K · filed 2026-02-06 | |||
| 2024-12-31 | $188.00M 10-K · filed 2026-02-06 | |||
| 2023-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $111.00M derived: sum of 2 quarters · filed 2026-02-06 | $158.00M derived: sum of 3 quarters · filed 2026-02-06 | $193.00M 10-K · filed 2026-02-06 |
| 2023-09-30 | $68.00M 10-Q · filed 2023-10-18 | $115.00M derived: sum of 2 quarters · filed 2023-10-18 | $150.00M 10-Q · filed 2023-10-18 | $195.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $47.00M 10-Q/A · filed 2023-09-29 | $84.00M 10-Q/A · filed 2023-09-29 | $127.00M derived: sum of 3 quarters · filed 2025-02-20 | $172.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $37.00M 10-Q · filed 2023-04-19 | $80.00M derived: sum of 2 quarters · filed 2025-02-20 | $125.00M derived: sum of 3 quarters · filed 2025-02-20 | $168.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $88.00M derived: sum of 2 quarters · filed 2025-02-20 | $131.00M derived: sum of 3 quarters · filed 2025-02-20 | $175.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $45.00M 10-Q · filed 2023-10-18 | $88.00M derived: sum of 2 quarters · filed 2023-10-18 | $132.00M 10-Q · filed 2023-10-18 | $298.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $43.00M 10-Q/A · filed 2023-09-29 | $87.00M 10-Q/A · filed 2023-09-29 | $253.00M derived: sum of 3 quarters · filed 2024-02-21 | $299.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $39.00M 10-Q · filed 2023-04-19 | $210.00M derived: sum of 2 quarters · filed 2024-02-21 | $256.00M derived: sum of 3 quarters · filed 2024-02-21 | $301.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $171.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $217.00M derived: sum of 2 quarters · filed 2024-02-21 | $262.00M derived: sum of 3 quarters · filed 2024-02-21 | $302.00M 10-K · filed 2024-02-21 |
| 2021-09-30 | $46.00M 10-Q · filed 2022-10-19 | $91.00M derived: sum of 2 quarters · filed 2022-10-19 | $131.00M 10-Q · filed 2022-10-19 | $202.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2021-06-30 | $45.00M 10-Q · filed 2022-07-20 | $85.00M 10-Q · filed 2022-07-20 | $156.00M derived: sum of 3 quarters · filed 2023-10-18 | $438.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2021-03-31 | $40.00M 10-Q · filed 2022-04-20 | $111.00M derived: sum of 2 quarters · filed 2023-10-18 | $393.00M derived: sum of 3 quarters · filed 2023-10-18 | $462.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2020-12-31 | $71.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-10-18 | $353.00M derived: sum of 2 quarters · filed 2023-10-18 | $422.00M derived: sum of 3 quarters · filed 2023-10-18 | $479.00M 10-Q · filed 2023-10-18 |
| 2020-09-30 | $282.00M 10-Q · filed 2021-10-20 | $351.00M derived: sum of 2 quarters · filed 2021-10-20 | $408.00M 10-Q · filed 2021-10-20 | $477.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $69.00M 10-Q · filed 2021-07-21 | $126.00M 10-Q · filed 2021-07-21 | $195.00M derived: sum of 3 quarters · filed 2022-02-16 | $248.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $57.00M 10-Q · filed 2021-04-21 | $126.00M derived: sum of 2 quarters · filed 2022-02-16 | $179.00M derived: sum of 3 quarters · filed 2022-02-16 | $232.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $122.00M derived: sum of 2 quarters · filed 2022-02-16 | $175.00M derived: sum of 3 quarters · filed 2022-02-16 | $228.00M 10-K · filed 2022-02-16 |
| 2019-09-30 | $53.00M 10-Q · filed 2020-10-28 | $106.00M derived: sum of 2 quarters · filed 2020-10-28 | $159.00M 10-Q · filed 2020-10-28 | |
| 2019-06-30 | $53.00M 10-Q · filed 2020-07-29 | $106.00M 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $53.00M 10-Q · filed 2020-04-29 | |||
| 2018-12-31 | $207.00M 10-K · filed 2021-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |